Cargando…
Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission
Podocyte injury underlies many forms of glomerular diseases. Our previous study showed that hyperoside, a naturally occurring flavonoid, could decrease albuminuria at the early stage of diabetic nephropathy by ameliorating renal damage and podocyte injury. However, its protective mechanism against p...
Autores principales: | Chen, Zhuyun, An, Xiaofei, Liu, Xi, Qi, Jia, Ding, Dafa, Zhao, Min, Duan, Suyan, Huang, Zhimin, Zhang, Chengning, Wu, Lin, Zhang, Bo, Zhang, Aihua, Yuan, Yanggang, Xing, Changying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687646/ https://www.ncbi.nlm.nih.gov/pubmed/29179476 http://dx.doi.org/10.18632/oncotarget.21287 |
Ejemplares similares
-
Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function
por: Zhao, Chuanyan, et al.
Publicado: (2017) -
Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
por: An, Xiaofei, et al.
Publicado: (2017) -
Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy
por: Zhu, Huanhuan, et al.
Publicado: (2020) -
Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
por: Zhang, Chengning, et al.
Publicado: (2020) -
Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease
por: Duan, Suyan, et al.
Publicado: (2021)